Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 400.19 | 361.04 | 337.42 | 242.75 |
Total Revenue | 400.19 | 361.04 | 337.42 | 242.75 |
Costof Revenue Total | 82.96 | 75.86 | 87.38 | 57.27 |
Gross Profit | 317.23 | 285.17 | 250.03 | 185.48 |
Selling/ General/ Admin Expenses Total | 68.93 | 66.19 | 56.70 | 43.27 |
Depreciation/ Amortization | 17.98 | 14.91 | 13.59 | 12.47 |
Other Operating Expenses Total | 160.46 | 143.58 | 118.97 | 92.98 |
Total Operating Expense | 330.34 | 301.23 | 276.65 | 205.99 |
Operating Income | 69.86 | 59.81 | 60.77 | 36.76 |
Interest Inc( Exp) Net- Non- Op Total | -71.05 | -42.21 | -57.18 | -81.77 |
Other Net | 5.29 | -0.07 | -0.86 | -0.35 |
Net Income Before Taxes | 68.04 | 55.97 | 54.08 | 28.88 |
Provisionfor Income Taxes | 20.27 | 16.96 | 12.42 | 7.79 |
Net Income After Taxes | 47.77 | 39.01 | 41.66 | 21.09 |
Net Income Before Extra Items | 47.77 | 39.01 | 41.66 | 21.09 |
Net Income | 47.77 | 39.01 | 41.66 | 21.09 |
Income Availableto Com Excl Extra Ord | 47.77 | 39.01 | 41.66 | 21.09 |
Income Availableto Com Incl Extra Ord | 47.77 | 39.01 | 41.66 | 21.09 |
Diluted Net Income | 47.77 | 39.01 | 41.66 | 21.09 |
Diluted Weighted Average Shares | 8.01 | 8.21 | 8.21 | 8.21 |
Diluted EPS Excluding Extra Ord Items | 5.96 | 4.75 | 5.08 | 2.57 |
DPS- Common Stock Primary Issue | 2.50 | 0.00 | 0.00 | 0.00 |
Diluted Normalized EPS | 5.96 | 4.77 | 5.09 | 2.51 |
Unusual Expense( Income) | - | 0.69 | 0.00 | 0.00 |
Gain( Loss)on Saleof Assets | - | 4.51 | -1.14 | 6.48 |
GPT Healthcare Dividend GPT Healthcare Bonus GPT Healthcare News GPT Healthcare AGM GPT Healthcare Rights GPT Healthcare Splits GPT Healthcare Board Meetings GPT Healthcare Key Metrics GPT Healthcare Shareholdings GPT Healthcare Balance Sheet GPT Healthcare Cashflow GPT Healthcare Q1 Results GPT Healthcare Q2 Results GPT Healthcare Q3 Results GPT Healthcare Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks